Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
BROWN, K. & CROFTS, N. « Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users », Australian and New Zealand Journal of Public Health, no 22, 1998, p.